Skip to Content
Morningstar

IDEXX Laboratories Inc IDXX

Morningstar Rating
Unlock
Stock XNAS Rating as of
$504.00 −2.12 (0.42%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Idexx's Upcoming New InVue Platform Launch Should Support Growth Into the Long Term

Debbie Wang

Idexx Laboratories has steadily increased its scale and reach in the veterinary diagnostic lab business to dig a narrow moat. It is well-positioned to benefit from two key trends. First, pet ownership continues to grow, offering a secular tailwind since the late 1980s. Moreover, pet owners have demonstrated greater willingness to spend more on their animals, having more than tripled spending on pet products and services since 1994.

Read Full Report

Price vs Fair Value

View History
IDXX is trading at a 315% premium.
Price
$504.00
Fair Value
$817.00
Uncertainty
Medium
1-Star Price
$214.00
5-Star Price
$194.00
Economic Moat
Tncgrs
Capital Allocation
Smfczpmfj

Bulls Say, Bears Say

Bulls

Unlike human healthcare, pet health services and products require cash payments—thereby bypassing the reimbursement issues and pricing pressure associated with third-party payers.

Bears

International sales account for a substantial chunk of Idexx's total revenue; as the U.S. dollar strengthens, Idexx would feel the pain on its top and bottom lines.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IDXX is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$506.12
Day Range
$500.52–508.90
52-Week Range
$372.50–583.39
Bid/Ask
$480.00 / $536.00
Market Cap
$41.62 Bil
Volume/Avg
386,651 / 477,082

Key Statistics

Price/Earnings (Normalized)
49.17
Price/Sales
11.36
Dividend Yield (Trailing)
—
Dividend Yield (Forward)
—
Total Yield
0.52%

Company Profile

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Mid Growth
Total Number of Employees
11,000
Website
https://www.idexx.com

Competitors

Valuation

View More
Metric
IDXX
ZTS
Price/Earnings (Normalized)
 49.1731.64
Price/Book Value
 26.7215.41
Price/Sales
 11.369.00
Price/Cash Flow
 42.1427.32
Price/Earnings
IDXX
ZTS

Financial Strength

Metric
IDXX
ZTS
Quick Ratio
 1.021.71
Current Ratio
 1.573.33
Interest Coverage
 30.6813.06
Quick Ratio
IDXX
ZTS

Profitability

Metric
IDXX
ZTS
Return on Assets (Normalized)
 29.78%17.68%
Return on Equity (Normalized)
 73.17%51.21%
Return on Invested Capital (Normalized)
 38.93%22.36%
Return on Assets
IDXX
ZTS
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Diagnostics & Research Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
KxgxcjszqWppt$218.4 Bil
 Danaher Corp
DHR
TrfhqvjnpWfmsjqx$188.8 Bil
 IQVIA Holdings Inc
IQV
WtbfnqtnGnbvmc$38.8 Bil
 Agilent Technologies Inc
A
KmdlspddnxSpc$37.9 Bil
 Mettler-Toledo International Inc
MTD
VhtxqtflpWsvyrd$31.1 Bil
 Icon PLC
ICLR
KgltnmsMckzpp$25.9 Bil
 Waters Corp
WAT
QfmpmxjztmDcgn$17.5 Bil
 Illumina Inc
ILMN
SsqnhznDynjng$17.3 Bil
 Labcorp Holdings Inc
LH
GfrcykrmgGhqsy$16.8 Bil

Sponsor Center